# Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application Total Hip Arthroplasty

> **NCT03623789** · PHASE4 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Hip Replacement, Total

## Interventions

- **DRUG:** intravenous application of tranexamic acid
- **DRUG:** Floseal hemostatic matrix
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03623789
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-15
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03623789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03623789, "Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03623789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*